Drug-Eluting Stents

A Global Strategic Business Report

MCP-1407


QUESTIONNAIRE EXECUTIVES DATA ROOM
  

HIGHLIGHTS & REPORT INDEX

Global Drug-Eluting Stents Market to Reach US$11.7 Billion by 2030

The global market for Drug-Eluting Stents estimated at US$7.8 Billion in the year 2023, is expected to reach US$11.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Polymer-Free, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Polymer-based segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 9.6% CAGR

The Drug-Eluting Stents market in the U.S. is estimated at US$2.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Drug-Eluting Stents Market - Key Trends and Drivers Summarized

What Are Drug-Eluting Stents and How Do They Function?

Drug-eluting stents (DES) are specialized medical devices used to treat coronary artery disease (CAD), a condition characterized by the narrowing of coronary arteries due to plaque buildup. These stents are tiny mesh tubes coated with medication that is gradually released to prevent the artery from becoming blocked again, a process known as restenosis. The structure of a drug-eluting stent includes a metal scaffold to provide mechanical support to the artery, and a polymer coating that controls the release of the drug over time. The drug inhibits cell proliferation and reduces inflammation, which are critical factors in preventing restenosis. By combining mechanical and pharmacological approaches, DES offer a significant improvement over bare-metal stents (BMS), which only provide structural support and are associated with higher rates of restenosis.

How Have Technological Advancements Improved Drug-Eluting Stents?

The field of drug-eluting stents has seen remarkable technological advancements that have enhanced their efficacy and safety profiles. Innovations in stent design, such as thinner struts and more flexible materials, have improved the deliverability and conformability of the stents, allowing for easier navigation through complex arterial pathways. The development of biodegradable polymers, which gradually dissolve after delivering the drug, has reduced long-term complications associated with permanent polymer residues. Advances in drug formulations have also played a crucial role, with newer drugs offering better control over cell proliferation and inflammation. Imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have further refined the deployment process by providing real-time, high-resolution images of the arteries, ensuring precise placement and optimal expansion of the stents. These technological improvements collectively contribute to better patient outcomes, reducing the incidence of adverse events and the need for repeat interventions.

What Are the Clinical Applications and Benefits of Drug-Eluting Stents?

Drug-eluting stents are primarily used in the treatment of coronary artery disease, but their applications extend to other vascular conditions as well. They are employed in the management of peripheral artery disease (PAD), where they help to open narrowed arteries in the legs, enhancing blood flow and reducing symptoms like pain and fatigue. The use of DES in treating complex lesions, such as those in patients with diabetes or multivessel disease, has shown promising results, offering a safer and more effective alternative to surgical interventions. The primary benefits of DES include a lower risk of restenosis and reduced need for repeat revascularization procedures, leading to improved long-term patient outcomes. Additionally, the minimally invasive nature of stent implantation, combined with shorter hospital stays and faster recovery times compared to open-heart surgery, makes DES a preferred option for many patients and healthcare providers.

What Drives the Growth in the Drug-Eluting Stents Market?

The growth in the drug-eluting stents market is driven by several factors, including technological advancements, increasing prevalence of cardiovascular diseases, and expanding healthcare infrastructure. The rising incidence of coronary artery disease, partly due to lifestyle changes and an aging population, is significantly boosting the demand for effective treatment options like DES. Advances in stent technology, such as the development of next-generation stents with enhanced biocompatibility and drug delivery mechanisms, are propelling market growth. Additionally, the growing preference for minimally invasive procedures among patients and healthcare providers is driving the adoption of DES over traditional surgical methods. Regulatory approvals and favorable reimbursement policies are also playing a crucial role in expanding the market reach. Furthermore, increasing investments in research and development by key industry players and the expansion of healthcare facilities in emerging markets are creating new opportunities for growth. The integration of advanced imaging technologies with stent deployment procedures is improving clinical outcomes, further strengthening the case for DES in cardiovascular treatment protocols. These factors, combined with a greater awareness of heart health and proactive management of cardiovascular conditions, are driving the robust growth of the drug-eluting stents market.

SCOPE OF STUDY

The report analyzes the Drug-Eluting Stents market in terms of US$ Million by the following Application; Coating; End-Use, and Geographic Regions/Countries:

Segments:
Coating (Polymer-Free, Polymer-based); Application (Coronary Artery Disease, Peripheral Artery Disease); End-Use (Cardiology Centers, Ambulatory Surgery Centers, Hospitals).

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Abbott Laboratories; AlviMedica; Arterius Limited; Biotronik SE; Boston Scientific Corporation; Cook Medical; Medtronic plc ; STENTYS SA; Terumo Corporation

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Drug-Eluting Stents – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Advancements in Stent Design Propel Growth in Drug-Eluting Stents Market
Increasing Prevalence of Cardiovascular Diseases Expands Addressable Market Opportunity
Innovations in Biodegradable Polymers Strengthen Business Case for Next-Generation Stents
Advances in Drug Formulations Enhance Efficacy and Reduce Complications
Growing Geriatric Population Generates Increased Demand for Cardiovascular Treatments
Trends in Personalized Medicine and Patient-Specific Solutions Propel Market Growth
Expansion of Healthcare Infrastructure in Emerging Markets Creates New Opportunities
Integration of Imaging Technologies and Stent Deployment Techniques Improves Outcomes
Focus on Long-Term Patient Outcomes and Reduced Restenosis Rates Sustains Growth
Adoption of Advanced Manufacturing Processes Enhances Stent Quality and Performance
Development of Dual Therapy Stents and Combination Products Generates New Market Segments
Impact of Lifestyle Changes and Risk Factors on Cardiovascular Health Drives Market Demand
4. GLOBAL MARKET PERSPECTIVE
World Drug-Eluting Stents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
World Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Drug-Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Polymer-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Polymer-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Polymer-Free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Polymer-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Polymer-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Polymer-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Cardiology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
UNITED STATES
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
USA Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
USA Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
USA 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
USA Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
USA Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
USA 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
USA Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
USA Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
USA 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
CANADA
Canada Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Canada Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Canada 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Canada Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Canada Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Canada 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Canada Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Canada Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Canada 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
JAPAN
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Japan Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Japan Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Japan 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Japan Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Japan Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Japan 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Japan Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Japan Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Japan 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
CHINA
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
China Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
China Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
China 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
China Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
China Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
China 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
China Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
China Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
China 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
EUROPE
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Europe Historic Review for Drug-Eluting Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Europe 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Europe Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Europe 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Europe Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Europe 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Europe Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Europe 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
FRANCE
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
France Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
France Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
France 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
France Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
France Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
France 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
France Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
France Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
France 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
GERMANY
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Germany Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Germany Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Germany 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Germany Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Germany Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Germany 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Germany Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Germany Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Germany 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
ITALY
Italy Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Italy Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Italy 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Italy Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Italy Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Italy 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Italy Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Italy Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Italy 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
UNITED KINGDOM
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
UK Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
UK Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UK 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
UK Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
UK Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UK 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
UK Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
UK Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UK 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
SPAIN
Spain Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Spain Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Spain 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Spain Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Spain Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Spain 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Spain Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Spain Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Spain 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
RUSSIA
Russia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Russia Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Russia 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Russia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Russia Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Russia 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Russia Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Russia Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Russia 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Europe Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Europe 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Europe Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Europe 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Europe Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Europe 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Asia-Pacific Historic Review for Drug-Eluting Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Asia-Pacific Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Asia-Pacific Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Asia-Pacific Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
AUSTRALIA
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
Australia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Australia Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Australia 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Australia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Australia Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Australia 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Australia Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Australia Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Australia 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
INDIA
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
India Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
India Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
India 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
India Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
India Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
India 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
India Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
India Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
India 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
South Korea Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
South Korea 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
South Korea Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
South Korea Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
South Korea 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
South Korea Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
South Korea Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
South Korea 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Asia-Pacific Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
LATIN AMERICA
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Latin America Historic Review for Drug-Eluting Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Latin America 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Latin America Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Latin America 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Latin America Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Latin America 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Latin America Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Latin America 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Argentina Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Argentina 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Argentina Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Argentina Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Argentina 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Argentina Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Argentina Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Argentina 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
BRAZIL
Brazil Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Brazil Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Brazil 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Brazil Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Brazil Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Brazil 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Brazil Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Brazil Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Brazil 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
MEXICO
Mexico Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Mexico Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Mexico 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Mexico Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Mexico Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Mexico 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Mexico Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Mexico Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Mexico 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Latin America Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Latin America 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Latin America Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Latin America 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Latin America Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Latin America 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
MIDDLE EAST
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Middle East Historic Review for Drug-Eluting Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Middle East 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Middle East Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Middle East 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Middle East Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Middle East 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Middle East Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Middle East 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
IRAN
Iran Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Iran Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Iran 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Iran Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Iran Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Iran 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Iran Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Iran Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Iran 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
ISRAEL
Israel Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Israel Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Israel 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Israel Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Israel Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Israel 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Israel Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Israel Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Israel 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Saudi Arabia Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Saudi Arabia 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Saudi Arabia Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Saudi Arabia 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Saudi Arabia Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Saudi Arabia 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
UAE Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UAE 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
UAE Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
UAE Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UAE 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
UAE Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
UAE Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UAE 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Middle East Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Middle East 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Middle East Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Middle East 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Rest of Middle East Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Rest of Middle East 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030
AFRICA
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Africa Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Africa Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Africa 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030
Africa Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Africa Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Africa 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030
Africa Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
Africa Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Africa 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

%

VALIDATED RESEARCH *

* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

[chatbot]